MT Newswires
Guardant Health Receives FDA Approval for Colorectal Cancer Diagnostic
📈
AI Sentiment
Highly Positive
8/10
Pfizer Inc. News
Latest updates and market news for PFE
16 news
Jan 18 - Jan 24, 2026
Page 1
Business Wire
Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
📈
AI Sentiment
Highly Positive
9/10
Motley Fool
Is Pfizer an Absurdly Cheap Dividend Stock, or Just a Value Trap?
âž–
AI Sentiment
Neutral
4/10
Reuters
Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality
📉
AI Sentiment
Negative
2/10
The Daily Upside
Johnson & Johnson Crushes Patent, Pricing Probs
Zacks
Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer
📈
AI Sentiment
Highly Positive
8/10
Zacks
Which Pharma Stock Stands Taller Right Now: LLY or PFE?
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
GSK Partner Shionogi to Acquire Pfizer's Stake in HIV-Focused ViiV Healthcare for $2.13 Billion
âž–
AI Sentiment
Neutral
5/10
Pharma Voice
Texas, N. Carolina, Ohio, Pennsylvania — where pharma manufacturing investments have surged
📈
AI Sentiment
Highly Positive
10/10
Simply Wall St.
Pfizer (PFE) Valuation Check As Investors Reassess Recent Shareholder Returns
📊
AI Sentiment
Positive
6/10
Benzinga
Congresswoman Violates STOCK Act With Over 200 Late Trade Disclosures: Purchases Include Mag7, Healthcare Stocks
📉
AI Sentiment
Negative
3/10
Share this news page